Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marcellin

Showing results (51-60 of 212) with videos related to

Pageof 22
Sort By:
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Treatment of viral hepatitis C]J M Pawlotsky, P Marcellin, C Trépo, et al.
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1996
[Treatment of chronic viral hepatitis]P Marcellin, J M Metreau, S Pol, et al.
European Journal of Clinical Investigation|August 1, 1994
Distribution of hepatitis B virus DNA sequences in different peripheral blood mononuclear cell subsets in HBs antigen-positive and negative patientsY Calmus, P Marcellin, G Beaurain, et al.
European Journal of Biochemistry|September 15, 1987
Effect of ethylene treatment on the concentration of fructose-2,6-bisphosphate and on the activity of phosphofructokinase 2/fructose-2,6-bisphosphatase in bananaE Mertens, P Marcellin, E Van Schaftingen, et al.
Gastroenterologie Clinique Et Biologique|September 9, 2008
[Treatment of chronic hepatitis B]T Asselah, O Lada, N Boyer, et al.
Journal of Viral Hepatitis|March 5, 2004
Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis CP E Golstein, M L Delforge, J Deviere, et al.
Minerva Gastroenterologica E Dietologica|April 7, 2007
Management of chronic hepatitis CT Asselah, N Boyer, M P Ripault, et al.
Lancet (London, England)|September 3, 1994
Retreatment with interferon-alpha of chronic hepatitis C virus infectionP Marcellin, N Boyer, M Pouteau, et al.
Hepatology (Baltimore, Md.)|April 25, 2000
Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patientsV Di Martino, T Thevenot, N Boyer, et al.
JAMA|April 14, 1989
Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfaD Larrey, P Marcellin, E Fréneaux, et al.
Pageof 22

Showing results (51-60 of 212) with videos related to

Sort By:
Pageof 22
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Treatment of viral hepatitis C]J M Pawlotsky, P Marcellin, C Trépo, et al.
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1996
[Treatment of chronic viral hepatitis]P Marcellin, J M Metreau, S Pol, et al.
European Journal of Clinical Investigation|August 1, 1994
Distribution of hepatitis B virus DNA sequences in different peripheral blood mononuclear cell subsets in HBs antigen-positive and negative patientsY Calmus, P Marcellin, G Beaurain, et al.
European Journal of Biochemistry|September 15, 1987
Effect of ethylene treatment on the concentration of fructose-2,6-bisphosphate and on the activity of phosphofructokinase 2/fructose-2,6-bisphosphatase in bananaE Mertens, P Marcellin, E Van Schaftingen, et al.
Gastroenterologie Clinique Et Biologique|September 9, 2008
[Treatment of chronic hepatitis B]T Asselah, O Lada, N Boyer, et al.
Journal of Viral Hepatitis|March 5, 2004
Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis CP E Golstein, M L Delforge, J Deviere, et al.
Minerva Gastroenterologica E Dietologica|April 7, 2007
Management of chronic hepatitis CT Asselah, N Boyer, M P Ripault, et al.
Lancet (London, England)|September 3, 1994
Retreatment with interferon-alpha of chronic hepatitis C virus infectionP Marcellin, N Boyer, M Pouteau, et al.
Hepatology (Baltimore, Md.)|April 25, 2000
Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patientsV Di Martino, T Thevenot, N Boyer, et al.
JAMA|April 14, 1989
Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfaD Larrey, P Marcellin, E Fréneaux, et al.
Pageof 22